Pacific Biosciences
PACB
#8185
Rank
HK$2.80 B
Marketcap
HK$9.02
Share price
-2.95%
Change (1 day)
-8.78%
Change (1 year)

Pacific Biosciences (PACB) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : HK$6.11 Billion

According to Pacific Biosciences 's latest financial reports the company's total liabilities are HK$6.11 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Pacific Biosciences - Total liabilities on balance sheet (from 2009 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31HK$6.05 B3.53%
2024-12-31HK$5.85 B-28.27%
2023-12-31HK$8.15 B-13.28%
2022-12-31HK$9.40 B-0.77%
2021-12-31HK$9.48 B1458.31%
2020-12-31HK$0.60 B-16.05%
2019-12-31HK$0.72 B64.66%
2018-12-31HK$0.44 B-2.82%
2017-12-31HK$0.45 B9.77%
2016-12-31HK$0.41 B-7.51%
2015-12-31HK$0.44 B-17.16%
2014-12-31HK$0.53 B3.66%
2013-12-31HK$0.51 B230.19%
2012-12-31HK$0.15 B-24.55%
2011-12-31HK$0.20 B3.55%
2010-12-31HK$0.20 B-90.66%
2009-12-31HK$2.15 B35.19%
2008-12-31HK$1.59 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Thermo Fisher Scientific
TMO
HK$480.31 B 7,748.73%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
HK$861.50 B 13,977.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
HK$30.46 B 397.82%๐Ÿ‡บ๐Ÿ‡ธ USA
PerkinElmer
PKI
HK$51.81 B 746.71%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoString Technologies
NSTG
HK$2.55 B-58.30%๐Ÿ‡บ๐Ÿ‡ธ USA